Off-Target Effects
Unintended edits at genomic sites that share partial sequence similarity with the intended CRISPR target, posing safety risks.
Off-Target Effects are unintended genetic modifications that occur when a CRISPR nuclease cleaves genomic sites with partial homology to the guide RNA target sequence 1.
How It Works
Off-target cleavage occurs because Cas9 can tolerate mismatches between the guide RNA and the DNA target, particularly in the PAM-distal region of the spacer. A guide with high on-target activity may still cut at dozens of off-target sites if those sites share sufficient sequence similarity, especially in the seed region (8-12 PAM-proximal nucleotides).
Several experimental methods detect off-target editing genome-wide. GUIDE-seq integrates short double-stranded tags at break sites to map cleavage locations. DISCOVER-seq uses chromatin immunoprecipitation of repair factors. CIRCLE-seq and Digenome-seq use cell-free or purified genomic DNA to identify potential cut sites with high sensitivity.
Strategies to minimize off-target effects include using high-fidelity Cas9 variants (eSpCas9, HiFi Cas9), truncated guide RNAs, paired nickases, and optimized delivery methods that limit nuclease exposure time. For therapeutic applications, comprehensive off-target profiling is required by regulatory agencies before clinical use 1.
Computational Considerations
Prediction tools align guide sequences against reference genomes, scoring potential off-target sites based on mismatch number, position, and type. Deep learning models trained on experimental datasets achieve higher accuracy than alignment-based methods alone, enabling prioritization of guides with favorable specificity profiles 2.
Woolf Software builds computational tools for genome editing design and off-target prediction. Get in touch.
Genome-wide off-target prediction algorithms score potential mismatch sites using deep learning models trained on GUIDE-seq and DISCOVER-seq datasets.
Related Terms
References
- Tsai SQ, Zheng Z, Nguyen NT, et al.. GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases . Nature Biotechnology (2015) DOI
- Doench JG, Fusi N, Sullender M, et al.. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9 . Nature Biotechnology (2016) DOI